To investigate the potential of spectral computed tomography (CT) (popularly referred to as multicolor CT), used in combination with a gold high-density lipoprotein nanoparticle contrast agent (Au-HDL), for characterization of macrophage burden, calcifi cation, and stenosis of atherosclerotic plaques.
to identify the type of tissue or material being scanned by using the characteristic energy-dependent attenuation of x-rays ( Fig 1a ) ( 17 ) . Although several methods can be used to interrogate the energy-dependant attenuation of the x-rays of materials ( 18 ) , this report is focused on energy-resolved photoncounting CT, or spectral CT. This technique involves the use of the x-ray spectrum from a single x-ray tube voltage with a special detector that allocates incident x-rays into six energy bins ( 19 ) . The information from these energy bins enables the identifi cation of materials by decomposing the total attenuation of the material into the various physical contributions for each pixel ( 20 ) . Feuerlein et al used this technique to improve imaging of the lumen, calcifi ed plaque, and stent material in an artery phantom ( 21 ) .
In 2008, we reported a targeted gold nanoparticle CT contrast agent based on high-density lipoprotein that is specifi c for macrophages ( 22 ) . This gold high-density lipoprotein nanoparticle contrast agent (Au-HDL) ( Fig 1b ) was used to identify the macrophagerich plaques in aortas excised from apolipoprotein E knockout (apo E-KO) mice by using a micro-CT scanner ( 22 ) . The purpose of this study was to investigate the potential of spectral CT (popularly referred to as multicolor CT), used in combination with Au-HDL, for characterization of the macrophage burden, calcifi cation, and stenosis of atherosclerotic plaques from a single scanning examination.
Materials and Methods
Philips Healthcare (Hamburg, Germany) supported this study by providing access to the experimental CT scanner and performing image processing. The authors who are not employees of or consultants R uptures of atherosclerotic plaques are the cause of about 70% of heart attacks ( 1 ). It is widely recognized that the risk of atherosclerotic plaque rupture and consequent adverse cardiovascular events is primarily related to the composition of the plaques ( 2 ) . One of the main factors associated with an elevated risk of plaque rupture is a high macrophage content ( 3, 4 ) . As a result, much work has been devoted to developing contrast material-enhanced imaging methods for determining the macrophage content of plaques ( 5-8 ).
Although magnetic resonance (MR) imaging and fl uorine 18 fl uorodeoxyglucose positron emission tomography (PET) are useful for imaging arteries such as the aorta and carotid arteries, and other peripheral vessels, the associated long image acquisition times combined with the motion in the chest make imaging of the coronary arteries with these techniques very challenging ( 7 ). Computed tomography (CT) is a competitive technique for imaging the coronary arteries because multidetector CT scanners can be used to acquire high-spatial-resolution images of the entire heart within 5 seconds ( 9 ). Consequently, CT used with iodine-based contrast material is now a highly regarded clinical technique for detecting stenosis ( 10, 11 ) , plaque buildup ( 12, 13 ) , and calcifi cation in the coronary arteries ( 14, 15 ) .
Recently, efforts have been made to derive more information from CT scans
Implication for Patient Care
Characterization and determinan tion of the vulnerability of plaque in the coronary arteries may be possible with further development of the spectral CT imaging system.
Advances in Knowledge
Multicolor CT can distinguish n between the attenuation due to a gold nanoparticle contrast agent (Au-HDL), an iodine-based contrast agent, and calcium-rich material.
Multicolor CT can identify n areas of Au-HDL accumulation in the arteries of atherosclerotic mice.
Au-HDL accumulation occurs prin marily in the macrophages of atherosclerotic tissue and hence potentially represents areas of plaque that is vulnerable to rupture. 
Phantom Preparation
Four phantoms were prepared for the studies described in this report. These phantoms contained Au-HDL, iodinated contrast agents, and calcium phosphate to simulate calcifi ed tissue in either water or meat. The four phantoms were a concentration series in water, a concentration series in meat, an Au-HDL and iopamidol-blended concentration series in water, and an artery phantom. We prepared the concentration series in water by diluting the stock solutions with phosphatebuffered saline. We prepared the concentration series in meat by mixing volumes of the stock solutions with were mounted on a direct-drive rotating gantry. Spectral CT scanning was performed at 50 m A and 130 keV by using six energy bins. The energy thresholds in the detector electronics of the 1024 individual detector pixels were adjusted to incident energies of 25, 34, 51, 80, 91, and 110 keV, which yielded the highest sensitivity for simultaneous imaging of iodine (k-edge energy, 33.2 keV) and gold (k-edge energy, 80.7 keV). Water, meat, and blended phantoms were imaged by using a geometric magnification factor of two, which resulted in an in-plane resolution of 0.25 mm (600 3 600 pixel image matrix), while the artery phantom and the apo E-KO mice (Jackson Laboratory, Bar Harbor, Me) were imaged by using a geometric magnifi cation factor of six, which resulted in an in-plane resolution of about 0.1 mm (400 3 400 pixel image matrix). We preprocessed the measured six-bin photon-counting raw data to correct for a variety of detector imperfections, such as dead time and gain variations, as described previously ( 20 ) . Afterward, the measured data were decomposed into material equivalents by using a maximum likelihood approach, as previously described ( 19 ) . For simultaneous imaging of two contrast materials, we
The phosphate concentration was determined by using the method of Rouser et al ( 23 ) . The protein concentration was determined by using the method of Markwell et al ( 24 ) , with adjustment for the light absorbance of the gold cores. Negative-stain TEM was performed by using a Hitachi H-7650 transmission electron microscope (Hitachi High Technologies, Pleasanton, Calif). Samples were prepared for TEM by using the method of Forte and Nordhausen ( 25 ) . The gold content was determined by means of inductively coupled plasma mass spectrometry (Cantest, Burnaby, British Columbia, Canada).
Spectral CT Scanner
The spectral CT scanner (Philips Healthcare) we used is an experimental research instrument that has been pre viously described in detail ( 20 ) . In brief, the scanner is equipped with a single-line, energy-sensitive photon-counting detector (Gamma Medica-Ideas, Northridge, Calif) with 3-mm-thick cadmium telluride sensor material. The x-ray source is a KEVEX PXS10-65 W microfocus tube (Thermo Scientifi c, Scotts Valley, Calif). The exit window for the x-ray tube is made from beryllium. Scanning was performed with a 2-mm-thick aluminum fi lter. The x-ray source and detector 
EXPERIMENTAL STUDIES: Multicolor CT Evaluation of Atherosclerotic Plaque Composition
Cormode et al images owing to their high effective atomic number. Tissue attenuates largely via the Compton effect and appears primarily on the Compton effect images ( Fig 2c) . As seen on these images, the gold, iodine, and photoelectric images correctly depicted the locations where gold, iodine, and calcium were present, and the gold and iodine images had an increasing linear signal as the contrast agent concentration increased (Figs E1, E2 [online]). The plastic of the tube holder, the tubes, and the water from the solutions were picked up on the Compton image. There was some cross talk from the calcium phosphate signal onto the gold and iodine images; however, this is not expected to be problematic, because in any biologic setting, there would not be gold or iodine accumulation in the same region as calcium-rich tissue and the cross talk could be subtracted by comparison with the calcium image. There was also a small amount of cross talk from the highest concentrations of gold onto the iodine image, and vice versa. Similar results were obtained when we prepared a range of contrast agent concentrations in a ground meat matrix ( Fig E3  [online] ).
To test the ability to determine the concentration of substances under confounding conditions with spectral CT, we constructed a phantom composed of mixtures of Au-HDL and iodinated contrast material. As seen in Figure E4 , A (online), there was roughly the same attenuation in each tube on the conventional CT image. The gold, iodine, photoelectric, and Compton images are displayed in Figure E4 , B (online), in which the ability to identify both the location and the relative concentrations of the contrast agents by using the spectral CT system is apparent. Even under these confounding conditions, use of the spectral CT system enabled calculations of the concentrations of gold and iodine with reasonable accuracy (Fig E4, C  [online] ).
Spectral CT of Atherosclerotic Artery Phantom
We constructed a phantom of an artery to provide further evidence that
Results

Nanoparticle Characterization
Negative-stain TEM images ( Fig 1c ) showed Au-HDL to be composed of gold cores (dark spots) individually incorporated into coatings (light rims). The gold cores had a mean diameter of 3.1 nm 6 0.5 (standard deviation), and the mean overall diameter of the whole nanoparticle was 7.2 nm 6 0.7. Analysis of the protein, phosphorous, and gold content and the nanoparticle size data revealed that the phospholipid-to-gold ratio was very close to theoretic values and that there were, on average, 1.3 protein molecules per particle, matching the expected values for high-density lipoproteins of this size ( 31 ).
Spectral CT of Contrast Agent Solutions
To examine the ability to distinguish gold, iodine, and calcifi ed tissue with spectral CT, we fi rst constructed a phantom composed of a concentration series of Au-HDL, an iodinated contrast agent, and calcium phosphate powder to simulate calcium-rich tissue ( Fig 2a ) . When the phantom was scanned with spectral CT, the energy bins were tuned to 25-34 keV, 34-51 keV, 51-80 keV, 80-91 keV, 91-110 keV, and 110-130 keV ( Fig 2b) . These images were adjusted so that the plastic of the phantom holder yielded a similar gray level on each energy bin image. The k edge of gold was 80.7 keV ( 32 ), which was clearly picked up on the images; the vials were brighter on the 80-91-keV bin image than on the 51-80-keV bin image. In the case of iodine, the k edge was 33.2 keV ( 32 ), which resulted in similar attenuation on the 25-34-keV and 34-51-keV bin images and a steady decline as the energy increased further. The attenuation in the calcium phosphate vial could be seen to decline very swiftly with increasing energy.
From the raw data of these energy bin images, we computed and reconstructed four images showing the attenuation due to gold, iodine, the photoelectric effect, and the Compton effect ( 20 ) . Bone and calcium-rich matter were prominent on the photoelectric raw ground beef. The arterial phantom was constructed inside a 1.5-mL centrifuge tube with nontreated meat, meat treated with Au-HDL and calcium phosphate (contained in a plastic package) around the periphery, and iopamidol fi lling the remaining volume of the tube bore.
Animal Experiments
We used an apo E-KO mouse model of atherosclerosis in these experiments ( 27 ) . These mice had been on the Western high-fat, high-cholesterol diet for an average of 10 months and were 1 year old at the time of the experiments. Age-matched wild-type mice (Jackson Laboratory) (fed on a regular chow diet) were used as controls. All of the mice were male and were housed and maintained in a purpose-designed facility. The local animal care and use committee approved all experiments. D.P.C. (4 years of experience) handled the mice.
The animals were injected, via the tail vein, with Au-HDL at a dose of 500 mg of gold per kilogram of body weight. They were sacrifi ced 24 hours later and frozen before being examined with CT scanning. Some of the mice were injected with 150 m l of an iodinated emulsion (Fenestra VC) ( 28 ) at 24 hours, 5 minutes before they were sacrifi ced. The mouse groups were as follows: apo E-KO mice injected with Au-HDL ( n = 2), apo E-KO mice injected with Au-HDL and the iodine-based contrast agent ( n = 3), and wild-type mice (controls) injected with Au-HDL ( n = 3).
Tissue TEM and Confocal Microscopy
The aortas of two apo E-KO mice injected with Au-HDL 24 hours earlier were excised, and 5-mm-long sections were cut from the arch, at the renal arteries and the bifurcation. Sections were prepared for TEM imaging by using standard methods ( 29 ) . One author (R.E.G., 39 years experience) prepared and analyzed the TEM sections. Another author (D.P.C., 4 years experience) prepared sections for confocal microscopy by using previously reported methods ( 30 ) . Further details regarding these experiments are provided in Appendix E1 (online).
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Cormode et al high attenuation in the lumen was due to the iodinated contrast agent, whereas the high attenuation in the plaque was due to Au-HDL accumulation ( Fig 4, E ) . Furthermore, the bones of the mice were clearly identifi ed on the calcium images, with little cross talk with the gold and iodine images. With this experiment, we showed that it is possible to image gold-and iodine-based contrast agents, as well as calcifi ed tissue, simultaneously by using spectral CT in a mouse. The online movies show all sections of the mouse depicted in Figure  4 , D and E .
Au-HDL Localization in Aorta
The cellular localization of Au-HDL in the aorta was investigated by using TEM and confocal microscopy. On TEM images, we found Au-HDL to be largely localized in macrophages (Fig E6, A -C [online]), whereas areas of hypointensity in other cell types and regions of as the arch, the region near the renal arteries, and the bifurcation ( Fig 4, A ) . When the gold images were examined, it was clear that the high attenuation in the aortas was due to accumulation of Au-HDL in the arteries of these mice ( Fig 4, B, C ) . In comparison, images in the wild-type mice injected with Au-HDL showed much lower attenuation in the aorta regions, with little signal on the gold images (Fig E5 [online] ).
In an additional experiment, we injected three apo E-KO mice with Au-HDL and then 24 hours later with an iodinated emulsion contrast agent (Fenestra VC) for imaging of small animal vasculature. In this setting, the energy bin data were processed into gold, iodine, calcium, and tissue images. As seen in Figure 4 , D , high attenuation was seen in the lumen of the aorta and in the plaque surrounding the aorta on the conventional CT images. Examination of the spectral images revealed that the spectral CT can be used to distinguish gold, iodine, and calcifi ed tissue ( Fig 3a ) . Spectral CT could be used to correctly resolve the signals from the different materials in the fi eld of view ( Fig 3b, 3c ) in this setting also.
Spectral CT of apo E-KO Mice
We used the apo E-KO mouse model of atherosclerosis to test the combination of spectral CT and Au-HDL for macrophage imaging in a biologic setting; Au-HDL has previously been shown to be macrophage specifi c ( 22 ) . First, we injected two apo E-KO mice with Au-HDL; then we sacrifi ced and froze the mice 24 hours after injection, prior to scanning. The energy bin data were decomposed into gold, tissue, and calcium images. On the conventional CT images of the aorta in these mice, areas of high attenuation were observed in regions known to accumulate substantial atherosclerotic plaques ( 27 ), such 
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Cormode et al is often acquired a long time (eg, 24-48 hours) later ( 33 ). This makes coregistering of the different images acquired challenging, and especially so when the area to be imaged comprises the coronary arteries-structures of constant movement. Spectral CT offers the ability to identify the locations of contrast agent accumulation during a single scanning examination, eliminating the need for preinjection scanning. On the other hand, fl uorine 18 fl uorodeoxyglucose (FDG) PET does not require a preinjection image because the contrast on the image is present only because of the injected contrast agent. However, FDG PET of the coronary arteries is challenging owing to the high uptake of FDG by the myocardium, which obscures the identifi cation of the coronary arteries. Moreover, the temporal and spatial resolution of MR imaging and PET are poor for coronary artery imaging ( 7 ). The scanning time of the described spectral CT system needs to be improved. One must bear in mind that state-of-the-art clinical scanners have multiple (ie, 64-320) detector rows ( 18 ) , and the preclinical system used in this tions such as mixtures of the gold-and iodine-based contrast agents. We also demonstrated the capability of the spectral CT system in the detection of Au-HDL that accumulated in the aortas of apo E-KO mice. The cells that these nanoparticles gathered in were macrophages, as determined by using TEM and confocal microscopy-a result that is in agreement with previous experiment fi ndings ( 22 ) . The spectral CT results, therefore, seem to refl ect the macrophage content of the plaque, and they point to the possibility for CT molecular imaging of macrophage burden in arteries. As became clear from our investigations, iodinated contrast agents and calcifi ed structures also can be simultaneously visualized. This method could offer the potential to simultaneously acquire information on stenosis, calcifi cation, and infl ammationthree valuable parameters of plaque characterization.
One of the drawbacks of many forms of molecular imaging, such as iron oxideand gadolinium-enhanced MR imaging, is the requirement to perform preinjection imaging. The postinjection image the plaque represented staining artifacts (Fig E6, D and E [online] ).
We further investigated the cellular localization of Au-HDL in plaque by using confocal microscopy. Sections were stained with CD68 for macrophages, and nuclei were stained with 4,6-diamidino-2-phenylindole. Representative images are shown in Figure E6 , F -I (online). As seen on these images, areas of nanoparticle accumulation (stained red) closely corresponded to areas that stained positive for macrophages (stained green), confi rming the macrophage specifi city of Au-HDL.
Discussion
In this study, we demonstrated that spectral CT enables multicolor imaging and can be used to accurately distinguish a gold-based contrast agent (Au-HDL) from an iodinated contrast agent, tissue, and calcium-rich matter on scans of phantoms in water or meat, an artery phantom, and apo E-KO mice in situ. Furthermore, the concentrations of the agents can be determined with good accuracy, even under confounding condi- 
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Cormode et al detection is clearly a limitation of CT, and it has been posited that molecular imaging would not be possible with use of CT ( 38 ) . The results of this study and others (39) (40) (41) indicate, however, that molecular imaging with CT could be possible for certain processes. Owing to the relative insensitivity of CT for contrast material detection, the low densities of macrophages will likely not be detected. Infl amed and unstable plaques are rich in macrophages. Therefore, this insensitivity may be a benefi cial feature, as there will be little signal from quiescent plaques. We plan to conduct studies with atherosclerotic rabbits to correlate infl ammation burden with CT attenuation.
spectral CT systems at a speed comparable to that of current clinical systems. The 500 mg/kg (2.53 mmol of gold per kilogram of body weight) dose of Au-HDL used is comparable to that used for commercially available iodinated contrast agents (370 mg/kg or 2.92 mmol of iodine per kilogram of body weight) ( 13 ). We chose a dose equivalent to the number of particles used in our previous MR imaging studies with high-density lipoprotein-based contrast agents ( 22, 37 ) . Nevertheless, we plan to perform dose-response studies to determine optimized dosing. From the current study results, it seems likely that the dose could be reduced by a factor of two to four. The sensitivity for contrast agent study has only one detector row, resulting in longer scanning times. Another crucial contributor to the scanning time duration, however, is the low x-ray fl ux under which the scanner can be operated because of the lower count-rate limit of the photon-counting detectors used, as compared with the count-rate limit of conventional CT detectors ( 20 ) . Nevertheless, the lengthy scanning times can be overcome by using a number of methods or various combinations thereof-for example, detectors with higher count-rate capability ( 34, 35 ) , detectors with a smaller area ( 21 ) , and vertically stacked detectors ( 36 ) . Therefore, we anticipate that it eventually will be feasible to perform imaging with In summary, we have demonstrated the potential of the described spectral CT imaging system for differentiation of gold, iodine, and calcifi ed material in atherosclerosis. The spectral CT imaging system, together with Au-HDL, can be used to detect macrophages in atherosclerosis while imaging the vasculature and calcifi ed tissue at the same time. This fi nding points to preclinical and clinical applications in atherosclerosis, and the described spectral CT system potentially could be used with other types of contrast agents to probe other biologic processes and diseases.
Practical applications: In this study, we focused on gold-and iodine-based contrast agents. Others, however, have used gadolinium-( 21 ) or bismuth-based contrast agents ( 42 ) , and the use of contrast agents based on many other elements is theoretically possible with spectral CT. Moreover, settings other than arterial infl ammation, such as arteries with stents ( 21 ), thrombus formation ( 42 ) , and renal disease ( 43 ) , may be probed by using spectral CT, and we anticipate further applications in cancer, cardiovascular disease, and bowel diseases.
